Opioid Use in Serious Illness
|
|
- Thomas Marsh
- 5 years ago
- Views:
Transcription
1 Opioid Use in Serious Illness Jeanie Youngwerth, MD University of Colorado School of Medicine Associate Professor of Medicine, Hospitalist Director, Palliative Care Service Associate Director, Colorado Palliative Medicine Fellowship Program Medical Director, Halcyon Hospice and Palliative Care Pain: Objectives Apply equianalgesic opioid conversions in acute pain management Discuss principles for opioid dosing and titration for acute pain Describe adjustments for opioids in the setting of renal or liver failure 47 y/o M with metastatic neuroendocrine tumor Oxycodone ER 80 mg po BID Hydromorphone IR 4 mg po q 4 hrs prn pain 6 tablets a day Acute pain crisis from tumor burden Cr 0.7;;LFTs WNL Put on PCA overnight by moonlighter
2 What are the most appropriate PCA settings? 1. Morphine IV basal 1 mg/hr;; demand 2 mg;; lockout 8 min 2. Hydromorphone IV basal 1 mg/hr;; demand 1 mg;; lockout 10 min 3. Oxycodone ER 80 mg po BID plus Hydromorphone IV no basal;; demand 0.2 mg;; lockout 6 min 4. Morphine IV basal 3 mg/hr;; demand 1.5 mg;; lockout 10 min PCA Errors #1 improper dose/quantity US Pharmacopeia 2004;; Hicks: Am J Health Syst Pharm Opioid Conversions Equianalgesic Dosing 1. Calculate total 24 hour total opioid dose 2. Convert to 24 hour new opioid equivalent 3. Adjust by 50-75% for incomplete cross tolerance 4. Triple check calculations 5. Constipation prophylaxis! EPEC Module ;; v1.0;; NCCN: Adult Cancer Pain v
3 Incomplete Cross Tolerance When switching from one opioid to another Tolerance developed to one opioid may not completely transfer to the new opioid Start the new opioid at 50-75% of the equianalgesic dose 60% good generalization Pasternak: Trends in Pharm Sciences 2001;; Ballantyne: NEJM 2003;; Mehta: Anaesth 2006;; v1.0;; NCCN: Adult Cancer Pain v Opioid Conversions Equianalgesic Dosing Current Opioid Total 24 hour Current Opioid = New Opioid Total 24 hour New Opioid (X) Choice of Opioid What is considered the gold standard opioid? Grass: Anesth Analg 2005.
4 1. Calculate total 24 hour opioid dose Oxycodone ER 160 mg / day + Hydromorphone IR 24 mg / day TDD = Morphine X mg IV / day 2. Convert to 24 hour new opioid equivalent Current Opioid New Opioid = Total 24 hour Current Total 24 hour New (X) Oxycodone 20 mg po Morphine 10 mg IV = Oxycodone 160 mg/day po Morphine IV X X = Morphine 80 mg IV/day 2. Convert to 24 hour new opioid equivalent Current Opioid New Opioid = Total 24 hour Current Total 24 hour New (X) Hydrom 7.5 mg po Morphine 10 mg IV = Hydrom 24 mg/day po Morphine IV X X = Morphine 32 mg IV/day
5 3. Adjust by 60% for incomplete x- tolerance Morphine = 112 mg IV / day X 0.6 = Morphine 67 mg IV / day * Pain Pearl * Adjust for incomplete cross tolerance 4. Triple check calculations 5. Constipation prophylaxis! -Senna 2 tabs po BID Hawley: JPSM 2008;; Librach: JPSM 2010;; Tarumi: JPSM 2013.
6 Morphine 67 mg IV / day PCA settings? Morphine 67 mg IV / day 24 hrs = 2.8 mg/hr Basal 3 mg/hr Demand dose Lockout time Nurse-bolus PCA Management FIRST ask yourself Opioid naïve or not??? PCA Parameters Basal Demand Lockout
7 PCA Basal Rate- Opioid Tolerant Convert 24 hour total opioid requirement to hourly rate (by equianalgesic dosing) Macintrye: Br J Anaesth 2001;; Lehmann: JPSM 2005;; Grass: Anesth Analg PCA Basal Rate- Opioid Naïve No basal rate Increased rates of respiratory depression No improvement in pain scores Sidebotham: JPSM 1997;; Macintrye: Br J Anaesth 2001;; Krenn: Euro J Pain 2001;; Didem: Can J Anesth 2003;; Grass: Anesth Analg 2005;; Herr: Iowa City Guideline Summary NGC
8 PCA Demand Dose- Opioid Tolerant 50% of the basal rate (50-100%) Grass: Anesth Analg PCA Demand Dose- Opioid Naive Morphine Outcome demand dose 0.5 mg Inadequate analgesia Opioid Naive 2 mg é Respiratory depression 1 mg Optimum balance Owen: Anaesth 1989;; Sidebotham: JPSM 1997.
9 PCA Lockout Time Based on time to peak effect IV: 8-10 min Plasma Concentration Cmax SC / IM: min PO / PR: min Time Half-life (t 1/2 ) PCA Lockout Time Morphine 7 vs 11 minutes Fentanyl 5 vs 8 minutes No difference in pain, anxiety or side effects Ginsberg: Pain 1995.
10 PCA Lockout Time 10 minutes is a standard interval Ginsberg: Pain 1995;; Macintrye: Br J Anaesth 2001;; Walder: Acta Anaesthesiol Scand 2001;; Grass: Anesth Analg PCA Nurse Initiated Bolus Not studied Up to twice the demand dose Grass: Anesth Analg Morphine 67 mg IV / day 24 hrs = 2.8 mg/hr Basal 3 mg/hr Demand dose 1.5 mg Lockout time 10 min Nurse-bolus 3 mg
11 PCA Dosing Summary Basal Rate Opioid naïve: none Opioid tolerant: Convert 24 hour total opioid requirement to hourly rate (by equianalgesic dosing) Demand Dose Opioid naïve: 1 mg IV Morphine equivalent Opioid tolerant: 50% (100%) of the basal rate Lockout Time 10 minutes Nurse Initiated Bolus Up to 2x the demand dose Nurse calls 3 hours later for patient with severe pain. What is the best next step when titrating the PCA for acute pain control? 1. Increase basal rate to 4 mg/hr 2. Increase demand dose to 3 mg 3. Decrease lockout time to 6 minutes 4. Opioid rotation to PCA IV Fentanyl 5. Add Oxycodone/Acetaminophen 5/325 one tablet oral q4 hours prn Opioid Titration Acute control: immediate release/prn Demand dose Chronic control: sustained release/scheduled Basal rate Hanks: British J Cancer 2001;; Grass: Anesth Analg 2005.
12 * Pain Pearl * Titrate the demand dose for acute pain PCA Demand Dose Titration Practically every 60 minutes and reevaluate Can change every minutes if needed Opioid Titration Pain Severity Increase Dose By Mild 25% Moderate 50% Severe 100% EPEC Module ;; NCCN Adult Cancer Pain V
13 PCA Basal Rate Titration Every 24 hours reasonable 8-24 hours to achieve steady state Avoid changing more frequently than q 8 hrs EPEC Module ;; APS PCA Basal Rate Titration Dose based on 24 hour total opioid usage Patient pain rating Your assessment Daily trend of 24 hr requirements PCA Titration Summary Basal rate Consider change ~ daily based on 24 hour use Demand dose Titrate for acute pain control é 25% mild pain é 50% moderate pain é 100% severe pain Lockout time 10 min
14 PCA to Oral Opioids Once stable opioid requirements for ~2 days Use TDD from PCA to calculate equianalgesic oral dose of new opioid Patient using TDD Morphine 130 mg IV / day PCA to Oral Opioid Current Opioid New Opioid = Total 24 hour Current Total 24 hour New (X) Morphine 10 mg IV Morphine 30 mg po = Morphine 130 mg/day IV Morphine po X X = Morphine 390 mg po/day (no x-tolerance needed)
15 PCA to Oral Opioid X = Morphine 390 mg po/day Morphine ER 200 mg po BID BTP? Avoid Mixing Opioids é risk for confusion and mistakes by patients and providers SIMPLIFY Morphine SR + Morphine IR prn NCCN: Adult Cancer Pain v * Pain Pearl * Breakthrough pain IR Dose: 10-15% of 24 hour total opioid dose Interval: time to peak effect NCCN: Adult Cancer Pain v
16 PCA to Oral Opioid X = Morphine 390 mg po/day Morphine ER 200 mg po BID BTP: Morphine IR 45 mg (30 mg x 1.5 tab) po q1 hr prn pain Or Morphine elixir 20 mg/ml 40 mg po q1 hr prn pain Poop Prophylaxis: Senna 2 tab po BID When to Avoid Morphine Renal Failure Majority of opioids renally cleared Recommendations based on presence of active metabolites Limited studies;; no RCTs No consensus on GFR Dean: J Pain Symptom Manage 2004;; King: Palliat Med 2011.
17 Renal Failure (RF) Morphine, Codeine Potent, active metabolites cleared renally Increased risk for neurotoxicity Avoid in RF Hydromorphone, Oxycodone, Tramadol Poorly studied Cautious dosing Fentanyl Limited studies No known active renal metabolites No dose adjustment short term in RF consider decreasing dose long term Dean: J Pain Symptom Manage 2004;; King: Palliat Med Liver Failure Impaired oxidation and glucuronidation Limited studies- most extrapolated from RF High prevalence & risk of RF in cirrhosis Avoid Morphine, Codeine, Tramadol Transdermal preparations Davis: Clin Pharmacokinet 2007;; Rhee: J Palliat Med 2007;; Chandok: Mayo Clin Proc * Pain Pearl * Avoid Morphine in renal/liver failure Fentanyl safer choice in RF Oxycodone and Hydromorphone cautious dosing Consider IR preparations Consider longer dosing intervals
18 Caveats Methadone Elderly Fentanyl TD Methadone Does not follow regular opioid principles! Recommend consulting Palliative Care or Pain Service for patients in acute pain crisis who are on Methadone Bruera: JPM Elderly- Opioid Reduction Require less opioid than younger patients to achieve same relief Opioid sensitivity é by 50% Pain intensity ê by 10-20% each decade after age 60 Herr: Iowa City Guideline Summary NGC
19 Elderly- Opioid Reduction Initiate opioids at 25-50% lower dose than recommended for younger adults Herr: Iowa City Guideline Summary NGC Evidence Grade = B;; v1.0. Fentanyl TD Chronic, stable pain in opioid-tolerant Lipophilic;; ê absorption in cachectic é absorption with heat (fevers) NCCN: Adult Cancer Pain v1.2016;; Reddy: JPSM Fentanyl TD 2x po Morphine Fentanyl TD 200 mg po QD 100 mcg/hr TD q3 days Fentanyl TD 2.4x po Morphine 100 mcg/hr TD q3 days 240 mg po QD NCCN: Adult Cancer Pain v1.2016;; Reddy: JPSM 2016.
20 Improve Pain: QI Projects PCA Safety Checklist Safe, effective, rapid pain control with a standardized, transparent approach PCA Safety Checklist FOR ALL STEPS: Document exceptions to any step of the safety checklist. Address psycho- social- spiritual pain. INITIATION Patient has confirmed cognitive function physical capability Patient and family educated Document PCA indication Discontinue all other opioids CALCULATIONS GUIDELINES 40% reduction for cross tolerance when converting to another opioid For basal and demand: Is demand % of basal rate? Is RN bolus % of demand? Is demand lockout 10 minutes? Double check calculations with a palliative care team member PCA conversion verbally communicated to primary team and nurse Is patient IPC bed status? Document conversion calculations (.pccalc and.pcpca) TITRATION CALCULATIONS GUIDELINES Incremental 24 hour basal rate increase not to exceed 100% of previous basal rate For basal and demand: Is demand % of basal rate? Is RN bolus % of demand? Is demand lockout 10 minutes? Double check previous 24 hour use with a palliative care team member Double check titration calculations with a palliative care team member PCA titration verbally communicated to primary team and nurse Document titration calculations (.pcpca) TRANSITIONING Patient has confirmed GI absorption renal function appropriate for medication CALCULATIONS GUIDELINES Stable PCA use x 48 hours 40% reduction for cross tolerance when converting to another opioid Is oral PRN dose 10-15% of total daily dose? Double check calculations with a palliative care team member Patient has confirmed outpatient insurance coverage outpatient provider follow up PO conversion verbally communicated to primary team and nurse Document conversion calculations (.pccalc) PCA Safety Checklist current 24 hour dose *** = New X current ratio*** new ratio*** Total X = *** mg Total X 60% incomplete cross tolerance = *** mg Based on this Date calculation, Basal patient's Demand report Lockout of pain, Total and Usemy assessment Avg per hour of patient, Recommend: **** PCA table Opioid: *** Date Basal Demand Lockout Total Use Avg per hour
21 Percent Decrease from Moderate- Severe Pain to No- Mild Pain Within 2 Days Cycle 1 = 85% Pre = 42% 14/18 Cycle 2 = 54% 11/17 13/21 7/14 9/18 Patients with ESAS pain scores assessed at day 1 and day 3 (or day 2, if day 3 data not available);; Data Collection Utilizing EPIC Reports Resources REMS NCCN Adult Cancer Pain Guidelines /f_guidelines.asp * Pain Pearls * Adjust for incomplete cross tolerance (60%) Titrate demand dose for acute pain 25% mild pain 50% moderate pain 100% severe pain BTP: 10-15% of TDD Avoid Morphine with renal / liver failure
Objectives. Patient Controlled Analgesia (PCA) Management in the Seriously Ill. Discuss principles for opioid dosing and titration for acute pain
Patient Controlled Analgesia (PCA) Management in the Seriously Ill Jeanie Youngwerth, MD University of Colorado School of Medicine Associate Professor of Medicine, Hospitalist Associate Director, Colorado
More informationApproach to Acute Pain Management
Approach to Acute Pain Management Jeanie Youngwerth, MD University of Colorado School of Medicine Associate Professor of Medicine, Hospitalist Director, Palliative Care Service Associate Director, Colorado
More informationOpioid Pearls and Acute Pain Management
Opioid Pearls and Acute Pain Management Jeanie Youngwerth, MD University of Colorado Denver Assistant Professor of Medicine, Hospitalist Associate Director, Colorado Palliative Medicine Fellowship Program
More informationEquianalgesic Dosing: Making Opioid Interchange Easier. Joseph Bubalo PharmD, BCPS, BCOP Oncology Clinical Pharmacist Assistant Professor Of Medicine
Equianalgesic Dosing: Making Opioid Interchange Easier Joseph Bubalo PharmD, BCPS, BCOP Oncology Clinical Pharmacist Assistant Professor Of Medicine 1 Why Change Opioids? Side Effects Insufficient Pain
More informationB. Long-acting/Extended-release Opioids
4 Opioid tolerance is assumed in patients already taking fentanyl 25 mcg/hr OR daily doses of the following oral agents for 1 week: 60 mg oral morphine, 30 mg oxycodone, 8 mg hydromorphone, 25 mg of oxymorphone
More informationPharmacologic Considerations for Managing Sickle Cell Pain Claire Saadeh, PharmD, BCOP May 5, 2015
Pharmacologic Considerations for Managing Sickle Cell Pain Claire Saadeh, PharmD, BCOP May 5, 2015 Table 1: Physiologic changes that occur during sickle cell pain crisis 1-3 Phase Description / Complications
More informationOpioid Case Studies. Thomas P. Pittelkow, D.O., M.P.H. Mayo Clinic College of Medicine Rochester, MN. September 29, MFMER slide-1
Opioid Case Studies Thomas P. Pittelkow, D.O., M.P.H. Mayo Clinic College of Medicine Rochester, MN September 29, 2016 2015 MFMER slide-1 Disclosures Relevant Financial Relationship(s) None Off Label and/or
More informationPAIN MANAGEMENT PGY-1. Aaron D. Storms, MD Carin van Zyl, MD Adult and Pediatric Palliative Care, LAC+USC Keck School of Medicine of USC
PAIN MANAGEMENT PGY-1 Aaron D. Storms, MD Carin van Zyl, MD Adult and Pediatric Palliative Care, LAC+USC Keck School of Medicine of USC Perception Matters A builder aged 29 came to the accident and emergency
More informationOpioid Conversions Mixture of Science and Art
Opioid Conversions Mixture of Science and Art Matthew J. Pingree, MD Assistant Professor Division of Pain Medicine Physical Medicine and Rehabilitation and Anesthesiology Mayo Clinic, Rochester Pingree.Matthew@Mayo.edu
More informationGUIDELINES ON THE MANAGEMENT OF PAIN DUE TO CANCER IN ADULTS
GUIDELINES ON THE MANAGEMENT OF PAIN DUE TO CANCER IN ADULTS Bristol Palliative Care Collaborative Contact Numbers: Hospital Specialist Palliative Care Teams: North Bristol 0117 4146392 UH Bristol 0117
More information4/3/2018. Management of Acute Pain Crises. Five Mistakes I ve made and why you shouldn t
Management of Acute Pain Crises Maggie O Connor, M.D. Retired Palliative Care Physician Hope is not the conviction that something will turn out well, but the certainty that something makes sense, regardless
More informationPALLIATIVE TREATMENT BY DR. KHRONGKAMOL SIHABAN MEDICAL ONCOLOGIST
PALLIATIVE TREATMENT BY DR. KHRONGKAMOL SIHABAN MEDICAL ONCOLOGIST TREATMENT IN ONCOLOGY Main treatment : surgery Neoadjuvant treatment : RT, CMT Adjuvant treatment : Tx micrometastatic disease -CMT,Targeted
More informationOpioid Rotation. Dr Bruno Gagnon, M.D., M.Sc.
Opioid Rotation Dr Bruno Gagnon, M.D., M.Sc. Associate Professor Department of Family Medicine and Emergency Medicine, Faculty of Medicine, Université Laval Consultant in Palliative Medicine CHU de Québec-Université
More informationOpioid Conversion Guidelines
Opioid Conversion Guidelines March 2015 Gippsland Region Palliative Care Consortium Clinical Practice Group Title Keywords Ratified Opioid, Conversion, Drug, Therapy, Palliative, Guideline, Palliative,
More informationArresting Pain without Getting Arrested
G. Jay Westbrook, M.S., R.N., CHPN - Clinical Director Compassionate Journey: An End-of-Life Clinical & Education Service CompassionateJourney@hotmail.com 818/773-3700 Arresting Pain without Getting Arrested
More informationLong Term Care Formulary HCD - 08
1 of 5 PREAMBLE Opioids are an important component of the pharmaceutical armamentarium for management of chronic pain. The superiority of analgesic effect of one narcotic over another is not generally
More informationInterprofessional Webinar Series
Interprofessional Webinar Series Opioids in the Medically Ill: Principles of Administration Russell K. Portenoy, MD Chief Medical Officer MJHS Hospice and Palliative Care Director MJHS Institute for Innovation
More informationOverview of Essentials of Pain Management. Updated 11/2016
0 Overview of Essentials of Pain Management Updated 11/2016 1 Overview of Essentials of Pain Management 1. Assess pain intensity on a 0 10 scale in which 0 = no pain at all and 10 = the worst pain imaginable.
More informationFighting the Good Fight: How to Convert Opioids Just Right!
Fighting the Good Fight: How to Convert Opioids Just Right! Tanya J. Uritsky, PharmD, BCPS, CPE Clinical Pharmacy Specialist - Pain Medication Stewardship Hospital of the University of Pennsylvania - Philadelphia,
More informationPain management. Coleman Palliative Care Conference: February 2016 Josh Baru MD Stacie Levine MD
Pain management Coleman Palliative Care Conference: February 2016 Josh Baru MD Stacie Levine MD Case #1 61 yo man with history of Stage 3 colon cancer, s/p resection and adjuvant chemotherapy with FOLFOX
More informationPAIN. TREATMENT TABLES Analgesics. NON-OPIOID ANALGESICS Generic Name Trade Names (Examples) Duration Initial Dose
NON-OPIOID SHORT-ACTING LONG-ACTING **** O PAIN TREATMENT TABLES Analgesics NON-OPIOID ANALGESICS Generic Name Trade Names (Examples) Duration Initial Dose Tramadol 50 mg Ultram Every 4 hours 1-2 tabs,
More information(30689) PROT Pain PCA Adult Patient Controlled Analgesia
Diagnosis Allergies Nursing Assess and Document PCA: 1. Assess and document pain rating, sedation level and respiratory rate every 2 hours; assess and document pain rating, sedation level and respiratory
More informationSupporting Last Days of Life Symptom Control Medication Guidance: Algorithm. Agitation & Anxiety
Agitation & Anxiety (Exclude or treat REVERSIBLE causes*) Patient is anxious / frightened, but lucid Patient is confused, agitated and / or hallucinating MIDAZOLAM 2.5-5mg s/c (Max total 24 hour dose of
More informationPain Management in Hospice and Palliative Care
Pain Management in Hospice and Palliative Care A Case-based Approach JoAnne Nowak, M.D. Merrimack Valley Hospice Revised November 2011 Objectives Use a case study approach to stimulate discussion and illustrate
More informationNarcotic Equivalence Converter Narcotic Route Dose Duration; Select a drug: mg Convert to: mg Adapted from Tarascon Pocket Pharmacopoeia.
Narcotic Equivalence Converter Narcotic Route Dose Duration; Select a drug: mg Convert to: mg Adapted from Tarascon Pocket Pharmacopoeia. Created: Monday, March 12. Online calculator to convert equianalgesic
More informationRELIEVING VIRGINIA S PAIN AND SUFFERING 3:45-4:45PM
PROVIDING QUALITY CARE TO PAIN PATIENTS IN IOWA RELIEVING VIRGINIA S PAIN AND SUFFERING 3:45-4:45PM ACPE UAN: 107-000-14-016-L05-P Activity Type: Application-Based 0.1 CEU/1.0 hr Learning Objectives for
More informationBJF Acute Pain Team Formulary Group
Title Analgesia Guidelines for Acute Pain Management (Adults) in BGH Document Type Issue no Clinical guideline Clinical Governance Support Team Use Issue date April 2013 Review date April 2015 Distribution
More information2017 Opioid Prescribing Module 401 N. Ewing St. Lancaster, Ohio (740) ~
2017 Opioid Prescribing Module 401 N. Ewing St. Lancaster, Ohio 43130 (740) 687-8000 ~ www.fmchealth.org Introduction The purpose of this module is to reduce the risk of adverse outcomes for adult patients
More informationOpioids in Serious Medical Illness
Opioids in Serious Medical Illness Jacob J. Strand, M.D. Assistant Professor of Medicine Medical Director, Palliative Care Clinical Services Mayo Clinic Mayo Clinic Opioid Conference 2013 MFMER slide-1
More informationANSWER # 1 PHARMACOLOGY. Methadone answers Stoltzfus 4/5/2012 METHADONE: WHY GRANDMA S TAKING A DIPHENYLHEPTANE (ANSWERS) JANUARY 26, 2017
METHADONE: WHY GRANDMA S TAKING A DIPHENYLHEPTANE (ANSWERS) JANUARY 26, 2017 Ky Stoltzfus, MD Assistant Professor, Internal Medicine University of Kansas Medical Center ANSWER # 1 Your response might be
More informationTips for Managing Acute Pain
Tips for Managing Acute Pain Daniel Johnson, MD, FAAHPM Kaiser Permanente University of Colorado Session Outline 1. Pseudoaddiction 2. Opioid Selection 3. PCA Titration 4. Co-Analgesics 5. Breakthrough
More informationPalliative Care for Primary Care Providers QUYNH BUI, MD MPH DECEMBER 2015
Palliative Care for Primary Care Providers QUYNH BUI, MD MPH DECEMBER 2015 Objectives Define palliative care and primary palliative care Describe the rationale for providing primary palliative care in
More informationE-Learning Module N: Pharmacological Review
E-Learning Module N: Pharmacological Review This Module requires the learner to have read Chapter 13 of the Fundamentals Program Guide and the other required readings associated with the topic. Revised:
More information1/21/14. Cancer Related Pain: Case-Based Pharmacology. Conflicts of Interest. Learning Objective
Cancer Related Pain: Case-Based Pharmacology Jeannine M. Brant, PhD, APRN, AOCN Oncology Clinical Nurse Specialist Nurse Scientist Billings Clinic Conflicts of Interest Jeannine Brant has served on the
More informationDrug Information Common to the Class of Extended-Release and Long-Acting Opioid Analgesics (ER/LA opioid analgesics) Avinza Butrans
FDA Blueprint for Prescriber Education for Extended-Release and Long-Acting Opioid Analgesics 7/9/2012 Drug Information Common to the Class of Extended-Release and Long-Acting Opioid Analgesics (ER/LA
More information10 mg hydrocodone equals how much oxycodone
Cari untuk: Cari Cari 10 mg hydrocodone equals how much oxycodone Posts about dilaudid 8 vs oxycodone 30 written by buyprescriptionmedication. Can you help me with the conversion of Oxycodone IR (5mg tab)
More informationBASICS OF OPIOID PRESCRIBING 10:30-11:45AM
PROVIDING QUALITY CARE TO PAIN PATIENTS IN IOWA BASICS OF OPIOID PRESCRIBING 10:30-11:45AM ACPE UAN: 107-000-14-013-L01-P Activity Type: Application-Based 0.125 CEU/1.25hr Learning Objectives for Pharmacists:
More informationPRESCRIBING GUIDELINES FOR SYMPTOM MANAGEMENT IN THE DYING PATIENT
PRESCRIBING GUIDELINES FOR SYMPTOM MANAGEMENT IN THE DYING PATIENT A collaboration between: St. Rocco s Hospice, Bridgewater Community Healthcare NHS Trust, NHS Warrington Clinical Commissioning Group,
More informationDemystifying Opioid Conversion Calculations
Demystifying Opioid Conversion Calculations Stephanie Cheng, PharmD, MPH, BCGP Clinical Pharmacist Hospice Pharmacy Solutions November 28, 2018 Learning Objectives After this presentation, you should be
More informationReview of Pain Management with Clinical and Regulatory Updates
Review of Pain Management with Clinical and Regulatory Updates Palliative Care Collaborative: 8 th Annual Regional Conference October 10, 2014 Michael Stellini, M.D.,M.S. Medical Director, Hospice and
More informationPain Management Dilemmas. Five Pain Dilemmas. Barriers: Meet Loretta. Daniel Johnson, MD, FAAHPM
Pain Management Dilemmas Daniel Johnson, MD, FAAHPM Kaiser Permanente University of Colorado Five Pain Dilemmas 1. Barriers to Pain Management 2. Selecting and Titrating Opioids 3. Managing PCAs 4. Using
More informationBeyond The Lockout Time. Kelcy Freeman, PharmD, BCPS April 20, 2017 REMEDI Pump Collaborative Spring Conference Chicago, IL
Beyond The Lockout Time Kelcy Freeman, PharmD, BCPS April 20, 2017 REMEDI Pump Collaborative Spring Conference Chicago, IL Disclosure I am a full-time employee of Smiths Medical, global provider of medical
More informationOPIOID- INDUCED NEUROTOXICITY*
OPIOID- INDUCED NEUROTOXICITY* Sriram Yennu MD, MS, FAAHPM Palliative Care, Rehabilitation and Integrative Medicine U.T. M.D. Anderson Cancer Center *Slide Deck courtesy Dept PRIM MDACC PATIENT #1: MRS
More informationPain Management Management in Hepatic Hepatic and and Renal Dysfunction
Pain Management in Hepatic and Renal Dysfunction Review the pharmacologic basis for medications used in pain management Identify pain medications which hshould ldbe avoided in patients with hepatic dysfunction
More informationPalliative and Hospice Care of the Terminally Ill Introduction
Palliative and Hospice Care of the Terminally Ill Introduction There has been an increase in life expectancy for men and women of all races to 77.6 years Leading causes of death in older patients are chronic
More informationDose equivalent of fentanyl patch to oxycontin
Dose equivalent of fentanyl patch to oxycontin 10-3-2018 Detailed dosage guidelines and administration information for OxyContin (oxycodone hydrochloride). Includes dose adjustments, warnings and precautions.
More informationSupportive Care. End of Life Phase
Supportive Care End of Life Phase Guidelines for Health Care Professionals In the care of patients with established renal failure who are in the last days of life References: Chambers E J (2004) End of
More informationAmber D. Hartman, PharmD Specialty Practice Pharmacist James Cancer Center & Solove Research Institute Ohio State University Medical Center
Pharmacologic Management of Pain Amber D. Hartman, PharmD Specialty Practice Pharmacist James Cancer Center & Solove Research Institute Ohio State University Medical Center Objectives Identify types of
More informationAcute Pain Management in the Hospital Setting. Alexandra Phan, PharmD PGY-1 Pharmacy Practice Resident Medical Center Hospital Odessa, TX
Acute Pain Management in the Hospital Setting Alexandra Phan, PharmD PGY-1 Pharmacy Practice Resident Medical Center Hospital Odessa, TX 2 What is Pain? An unpleasant sensory and emotional experience associated
More informationLearning Objectives. Case Example. From Coke to Pepsi or a cocktail? Rotating and adding opioids in advanced pediatric pain medicine
From Coke to Pepsi or a cocktail? Rotating and adding opioids in advanced pediatric pain medicine Stefan J. Friedrichsdorf, MD, FAAP Associate Professor of Pediatrics, University of Minnesota Medical School
More informationAnalgesia. This is widely used in palliative care. It has antipyretic and analgesic effects but no anti-
Page 1 of 8 Analgesia The World Health Organisation (WHO, 1990) has devised a model to assist health care professionals in the management of cancer pain. The recommendations include managing pain, by the
More informationSee Important Reminder at the end of this policy for important regulatory and legal information.
Clinical Policy: Reference Number: CP.CPA.259 Effective Date: 11.16.16 Last Review Date: 11.17 Line of Business: Commercial Revision Log See Important Reminder at the end of this policy for important regulatory
More informationCare of the Dying. For dosing in severe renal impairment see separate guidance for care of the dying in severe renal failure.
Care of the Dying Early diagnosis of the dying process allows for adequate preparation of the patient, the family and the carers. This clinical guidance covers the prescribing and management of patients
More informationMethadone: Essential Hospice Analgesic or Too Risky for Prime Time?
Methadone Background Methadone: Essential Hospice Analgesic or Too Risky for Prime Time? Developed originally as an antispasmodic and later used as an analgesic, starting in late 1940 s Used extensively
More informationTHE EAPC OPIOID GUIDELINES: PROCESS, RESULTS AND FUTURE DEVELOPMENT
1 THE EAPC OPIOID GUIDELINES: PROCESS, RESULTS AND FUTURE DEVELOPMENT Jaegtvolden 4-5 June 2012 14. 12. 2012 2 1 3 WHO ANALGESIC LADDER (1996) NSAID +/- Adjuvant STEP II OPIODS Opids for mild to moderate
More informationObjectives: What is your Definition of Pain? 8/16/2017
Safe Opioid Management for the Seriously Ill Patient Sam Perna, D.O. Objectives: MDB1 1) Participants will understand the way the body s pain system works. 2) Participants will identify the elements of
More informationEvidence-based Best Practice in Pain Management
Foundations in Palliative Medicine Colorado, November 2017 Evidence-based Best Practice in Pain Management Sudy Jahangiri, MD Crystal Owens, MD Continuing Education Disclosures Approval Statement: The
More informationOpioid Pain Management. John Manfredonia, DO. Disclosures. Dr. Manfredonia discloses his employment as Regional Medical Director for VistaCare
Opioid Pain Management John Manfredonia, DO Disclosures Dr. Manfredonia discloses his employment as Regional Medical Director for VistaCare VistaCare has provided commercial support for this activity Palliative
More informationPalliative Prescribing - Pain
Palliative Prescribing - Pain LAURA BARNFIELD 21/2/17 Aims To understand the classes of painkillers available in palliative care To gain confidence in counselling regarding opiates To gain confidence prescribing
More informationTo Infinity and Beyond! Safe and Effective Opioid Titration Strategies
To Infinity and Beyond! Safe and Effective Opioid Titration Strategies Alexandra L. McPherson, PharmD, MPH Slide development Mary Lynn McPherson, PharmD, MA, BCPS, CPE Professor and Executive Director,
More informationAcute pain management in opioid tolerant patients. Muhammad Laklouk
Acute pain management in opioid tolerant patients Muhammad Laklouk General principles An adequate review and assessment Provision of effective analgesia (including attenuation of tolerance and hyperalgesia)
More informationOpioid Conversion Ratios - Guide to Practice 2010
Opioid Conversion Ratios - Guide to Practice 2010 Released December 2010. 2010. The EMR PCC grants permission to reproduce parts of this publication for clinical and educational use only, provided that
More informationPain Management in the Hospital
E P E C O Pain Management in the Hospital Denise Waugh, MD FACEP FAAHPM Medical Director of Palliative Care Services Scott and White Healthcare 724-6859 Pain is a more terrible lord of mankind than even
More informationPeri operative pain control. Disclosure. Objectives 9/1/2011. No current conflicts of interest
Peri operative pain control Chris Herndon, PharmD, FASHP Southern Illinois University Edwardsville Disclosure No current conflicts of interest Objectives Discuss studies evaluating the transformation of
More information15mg oxycodone is equivalent to how much morphine
15mg oxycodone is equivalent to how much morphine The Borg System is 100 % 15mg oxycodone is equivalent to how much morphine nursing home activity director cover letter 15 mg oxycodone equal to how much
More information2-ethylidene-1,5-dimethyl-3,3diphenylpyrrolidene (EDDP) Safe in stable liver disease Long acting
2012 AAHPM & HPNA Annual Assembly March 7-10, 2012 Denver, CO Methadone the Taming of the Shrew Stefan J. Friedrichsdorf, M.D. Medical Director Department of Pain Medicine, Palliative Care & Integrative
More informationOpioid rotation or switching may be considered if a patient obtains pain relief with one opioid and is suffering severe adverse effects.
Dose equivalence and switching between opioids Key Messages Switching from one opioid to another should only be recommended or supervised by a healthcare practitioner with adequate competence and sufficient
More informationNATL. II. Health Net Approved Indications and Usage Guidelines: Diagnosis of cancer AND. Member is on fentanyl transdermal patches AND
Coverage of drugs is first determined by the member s pharmacy or medical benefit. Please consult with or refer to the Evidence of Coverage document I. FDA Approved Indications: The management of breakthrough
More informationSYMPTOM MANAGEMENT GUIDANCE FOR PATIENTS RECEIVING PALLIATIVE CARE AT ROYAL DERBY HOSPITAL
SYMPTOM MANAGEMENT GUIDANCE FOR PATIENTS RECEIVING PALLIATIVE CARE AT ROYAL DERBY HOSPITAL If a patient is believed to be approaching the end of their life, medication should be prescribed in anticipation
More informationLong-Acting Opioid Analgesics
Market DC Long-Acting Opioid Analgesics Override(s) Prior Authorization Step Therapy Quantity Limit Approval Duration Initial request: 3 months Maintenance Therapy: Additional prior authorization required
More informationLong-Acting Opioid Analgesics
Market DC Long-Acting Opioid Analgesics Override(s) Prior Authorization Step Therapy Quantity Limit Approval Duration Initial request: 3 months Maintenance Therapy: Additional prior authorization required
More informationLumbar Fusion. Reference Guide for PACU CLINICAL PATHWAY. All patient variances to the pathway are to be circled and addressed in the progress notes.
Reference Guide for PACU Lumbar Fusion CLINICAL PATHWAY All patient variances to the pathway are to be circled and addressed in the progress notes. This Clinical Pathway is intended to assist in clinical
More informationMorphine er to oxycontin conversion
Morphine er to oxycontin conversion The Borg System is 100 % Morphine er to oxycontin conversion 17-4-2011 Conversion dose from Oxycontin 40mg 3x a day to morphine sulfate 15 mg?. Oxycontin vs morphine
More informationManagement of Cancer Pain
Management of Cancer Pain Mihir M. Kamdar, MD Associate Director, Palliative Care Director, MGH Cancer Pain Clinic Depts of Anesthesia Pain/Palliative Care Massachusetts General Hospital None Disclosures
More informationPo dilaudid versus iv dilaudid
Po dilaudid versus iv dilaudid Search IM/IV/SC 120 mg ratios of morphine to methadone in patients with neuropathic pain versus non-neuropathic an equianalgesic ratio for PO. Dilaudid official prescribing
More informationClinical Guideline. Guidelines for the use of opioid analgesics in the management of acute pain in adults
Clinical Guideline Guidelines for the use of opioid analgesics in the management of acute pain in adults Document detail Document location West Kent and MTW Formulary Version 1.0 Effective from July 2017
More informationOAT Transitions - focus on microdosing. Mark McLean MD MSc FRCPC CISAM DABAM
OAT Transitions - focus on microdosing Mark McLean MD MSc FRCPC CISAM DABAM Disclosures No pharmaceutical industry or other financial conflicts of interest Study Physician for research funded by Canadian
More informationLimitations of use: Subsys may be dispensed only to patients enrolled in the TIRF REMS Access program (1).
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.70.21 Subject: Subsys Page: 1 of 5 Last Review Date March 17, 2017 Subsys Description Subsys (fentanyl
More informationCigna Drug and Biologic Coverage Policy
Cigna Drug and Biologic Coverage Policy Subject Transmucosal Fentanyl Effective Date... 4/15/2018 Next Review Date... 4/15/2019 Coverage Policy Number... 1018 Table of Contents Coverage Policy... 1 General
More informationReducing the risk of patient harm: A focus on opioids
Reducing the risk of patient harm: A focus on opioids New York State Partnership for Patients (NYSPFP) Initiative Regional Educational Session November 2013 1 Disclosure Matthew Fricker, Matthew Grissinger,
More informationSession II. Learning Objectives for Session II. Key Principles of Safe Prescribing. Benefits and Limitations of ER/LA Opioids
Learning Objectives for Session II Session II Best Practices for How to Start Therapy with ER/LA Opioids, How to Stop, and What to Do in Between Upon completion of this module, the participants will be
More informationGG&C Chronic Non Malignant Pain Opioid Prescribing Guideline
GG&C Chronic Non Malignant Pain Opioid Prescribing Guideline Background Persistent pain is common, affecting around five million people in the UK. For many sufferers, pain can be frustrating and disabling,
More informationOxymorphone (Opana ) is indicated for the relief of moderate-to-severe acute pain where the use of an opioid is appropriate.
Page 1 of 7 Policies Repository Policy Title Policy Number Schedule II Prior Authorization FS.CLIN.16 Application of Pharmacy Policy is determined by benefits and contracts. Benefits may vary based on
More informationOptimizing Your Quality of Life During Cancer Treatment: Pain & Side Effect Management
Optimizing Your Quality of Life During Cancer Treatment: Pain & Side Effect Management Eric Roeland, MD GI Oncology Palliative Medicine Pancreatic Cancer Patient Tool Belt Chemotherapy Surgery Pain & Symptom
More information1
Disclosures I do not have a vested interest in or affiliation with any corporate organization offering financial support or grant monies for this continuing education activity, or any affiliation with
More informationAttach patient label here. Physician Orders ADULT: Palliative Care Plan
Initiate Orders Phase Care Sets/Protocols/PowerPlans Initiate Powerplan Phase T;N, Phase: Palliative Care Phase, When to Initiate: Palliative Care Phase Admission/Transfer/Discharge Patient Status Initial
More informationFor patients and their carers this means smoother symptom control, better support in a crisis, and avoidance of admission if that is their choice.
Bedfordshire Palliative Care Palliative Care Medicines Guidance This folder has been produced to support professionals providing palliative care in any setting. Its aim is to make best practice in palliative
More informationAnalgesics: Management of Pain In the Elderly Handout Package
Analgesics: Management of Pain In the Elderly Handout Package Analgesics: Management of Pain in the Elderly Each patient or resident and their pain problem is unique. A complete assessment should be performed
More information15 mg morphine 10 mg hydrocodone
Cari untuk: Cari Cari 15 mg morphine 10 mg hydrocodone 3-2-2013 Convert From CALCULATED MORPHINE EQUIVALENT BY RESOURCE: Average ( mg ) Range ( mg ) Standard Deviation of Sample ( mg ) Hydrocodone. I usually
More informationPitfalls in Pain Management: Practical Solutions for Hospitalists
Pitfalls in Pain Management: Practical Solutions for Hospitalists Liz Merkle Hankollari, M.D. Assistant Professor Hospital Medicine/General Internal Medicine Duke University Hospital Topics for Discussion
More informationPAIN MANAGEMENT IN PATIENTS WITH CANCER, PART II
Learning Objectives PAIN MANAGEMENT IN PATIENTS WITH CANCER, PART II MINA LEE UNIVERSITY OF WASHINGTON MEDICAL CENTER/ SEATTLE CANCER CARE ALLIANCE CLINICAL PHARMACIST, GENERAL ONCOLOGY Understand the
More informationPain Management Strategies Webinar/Teleconference
Pain Management Strategies Webinar/Teleconference Barry K. Baines, MD April 16, 2009 Objectives Describe the principles of pain management. Identify considerations in the use of opioids. Describe the benefits
More informationPharmacokinetics of strong opioids. Susan Addie Specialist palliative care pharmacist
Pharmacokinetics of strong opioids Susan Addie Specialist palliative care pharmacist What is the difference between pharmacokinetics and pharmacodynamics? Definitions Pharmacokinetics = what the body does
More informationBerkshire West Area Prescribing Committee Guidance
Guideline Name Berkshire West Area Prescribing Committee Guidance Date of Issue: September 2015 Review Date: September 2017 Date taken to APC: 2 nd September 2015 Date Ratified by GP MOC: Guidelines for
More informationPAIN MANAGEMENT Patient established on oral morphine or opioid naive.
PAIN MANAGEMENT Patient established on oral morphine or opioid naive. Important; It is the responsibility of the prescriber to ensure that guidelines are followed when prescribing opioids. Every member
More informationPEDIATRIC SPINE SURGERY POST-OP PLAN - Phase:.
- Phase:. PHYSICIAN S Diagnosis Weight Allergies DETAILS Patient Care Patient Activity Bedrest Maintain Surgical Drain Maintain JP Drain, Measure Output q12h, and PRN Convert IV to INT when tolerating
More informationmorphine 30 mg/ 30 ml (1 mg/ml) Opioid of choice
PATIENT CONTROLLED ANALGESIA (PCA) PLAN Allergies: Medication Selection: morphine 30 mg/ 30 ml (1 mg/ml) Opioid of choice HYDROmorphone (Dilaudid ) 6 mg/ 30 ml (0.2 mg/ml) fentanyl 300 mcg/ 30 ml (10 mcg/ml)
More informationGUIDELINES FOR PRESCRIBING AT THE END OF LIFE FOR PATIENTS WITH RENAL IMPAIRMENT (estimated glomerular filtration rate<30)
GUIDELINES FOR PRESCRIBING AT THE END OF LIFE FOR PATIENTS WITH RENAL IMPAIRMENT These guidelines have been produced in collaboration with Dr Lucy Smyth, Consultant in Renal Medicine, Royal Devon and Exeter
More informationRegional Renal Training
Regional Renal Training Palliative and End of Life Care Dr Clare Kendall North Bristol NHS Trust Advanced Kidney Disease Dialysis/Transplant Conservative Management Deteriorating despite dialysis/failing
More informationEnd-of-Life Pain Management: How to do it right Wayne Kohan MD Medical Director Chaplaincy Hospice Care
End-of-Life Pain Management: How to do it right Wayne Kohan MD Medical Director Chaplaincy Hospice Care Objectives Discuss the rational use of opioid medications, including dosing and dose titration, routes
More information